Back to mobile site

H.C. Wainwright Reiterates Neutral Rating on CytoSorbents (CTSO)

March 26, 2026 6:49 AM EDT Send to a Friend
H.C. Wainwright analyst Sean Lee reiterated a Neutral rating and $0.75 price target on CytoSorbents (NASDAQ: CTSO).The analyst commented: "On ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login